Related references
Note: Only part of the references are listed.Chemo-Enzymatic PEGylation/POxylation of Murine Interleukin-4
Dorothee Haas et al.
BIOCONJUGATE CHEMISTRY (2022)
Linear Polyglycerol for N-terminal-selective Modification of Interleukin-4
Michael Tully et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2022)
Bioconjugation strategies and clinical implications of Interferon-bioconjugates
Niklas Hauptstein et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2022)
Ropeginterferon Alfa-2b administered every two weeks for patients with genotype 2 chronic hepatitis C
Shih-Jer Hsu et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2021)
Reincarnation of the Analytical Ultracentrifuge: Emerging Opportunities for Nanomedicine
Olenka Jibaja Valderrama et al.
ANALYTICAL CHEMISTRY (2021)
Molecular Insights into Site-Specific Interferon-α2a Bioconjugates Originated from PEG, LPG, and PEtOx
Niklas Hauptstein et al.
BIOMACROMOLECULES (2021)
Electrostatics Drive Oligomerization and Aggregation of Human Interferon Alpha-2a
Christin Pohl et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2021)
Inhibition of Herpes Simplex Virus Type 1 Attachment and Infection by Sulfated Polyglycerols with Different Architectures
Paria Pouyan et al.
BIOMACROMOLECULES (2021)
Polyglycerol for Half-Life Extension of Proteins-Alternative to PEGylation?
Michael Tully et al.
BIOMACROMOLECULES (2021)
Prolonged activity of exenatide: Detailed comparison of Site-specific linear polyglycerol- and poly(ethylene glycol)-conjugates
Michael Tully et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2021)
SimpleDSFviewer: A tool to analyze and view differential scanning fluorimetry data for characterizing protein thermal stability and interactions
Changye Sun et al.
PROTEIN SCIENCE (2020)
Comparison of elapegademase and pegademase in ADA-deficient patients and mice
L. Murguia-Favela et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2020)
Cysteine-specific protein multi-functionalization and disulfide bridging using 3-bromo-5-methylene pyrrolones
Yingqian Zhang et al.
NATURE COMMUNICATIONS (2020)
The Importance of Poly(ethylene glycol) Alternatives for Overcoming PEG Immunogenicity in Drug Delivery and Bioconjugation
Thai Thanh Hoang Thi et al.
POLYMERS (2020)
Biodistribution of Site-Specific PEGylated Fibroblast Growth Factor-2
Tessa Luehmann et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2020)
Raising the ribosomal repertoire
Christopher D. Reinkemeier et al.
NATURE CHEMISTRY (2020)
Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals
Gergely Tibor Kozma et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Tyrosine Conjugation Methods for Protein Labelling
Dimitri Alvarez Dorta et al.
CHEMISTRY-A EUROPEAN JOURNAL (2020)
Targeting interleukin-4 to the arthritic joint
Valerie Spieler et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Paul Bastard et al.
SCIENCE (2020)
Structure of an anti-PEG antibody reveals an open ring that captures highly flexible PEG polymers
Justin T. Huckaby et al.
COMMUNICATIONS CHEMISTRY (2020)
Site-Selective Protein Modification: From Functionalized Proteins to Functional Biomaterials
Jared A. Shadish et al.
MATTER (2020)
Polymer-drug conjugate therapeutics: advances, insights and prospects
Iriny Ekladious et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Metabolic Glycoengineering of Cell-Derived Matrices and Cell Surfaces: A Combination of Key Principles and Step-by-Step Procedures
Marcus Gutmann et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2019)
Site-selective protein conjugation at histidine
Karolina Peciak et al.
CHEMICAL SCIENCE (2019)
Bioorthogonal strategies for site-directed decoration of biomaterials with therapeutic proteins
Alexandra C. Braun et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Bioresponsive release of insulin-like growth factor-I from its PEGylated conjugate
Alexandra C. Braun et al.
JOURNAL OF CONTROLLED RELEASE (2018)
POx as an Alternative to PEG? A Hydrodynamic and Light Scattering Study
Mandy Grube et al.
MACROMOLECULES (2018)
Site-Specific Conjugated Insulin-like Growth Factor-I for Anabolic Therapy
Fang Wu et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2018)
Site-Specific Conjugated Insulin-like Growth Factor-I for Anabolic Therapy
Fang Wu et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2018)
Hydrodynamic Analysis Resolves the Pharmaceutically-Relevant Absolute Molar Mass and Solution Properties of Synthetic Poly(ethylene glycol)s Created by Varying Initiation Sites
Ivo Nischang et al.
ANALYTICAL CHEMISTRY (2017)
A Potent In Vivo Antitumor Efficacy of Novel Recombinant Type I Interferon
Kang-Jian Zhang et al.
CLINICAL CANCER RESEARCH (2017)
Type I Interferon in Chronic Virus Infection and Cancer
Laura M. Snell et al.
TRENDS IN IMMUNOLOGY (2017)
Site-Specific POxylation of Interleukin-4
Tessa Luehmann et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2017)
Site-Specific POxylation of Interleukin-4
Tessa Luehmann et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2017)
Polymerization of Ethylene Oxide, Propylene Oxide, and Other Alkylene Oxides: Synthesis, Novel Polymer Architectures, and Bioconjugation
Jana Herzberger et al.
CHEMICAL REVIEWS (2016)
Interleukin-4-Clicked Surfaces Drive M2 Macrophage Polarization
Tessa Luehmann et al.
CHEMBIOCHEM (2016)
Biocompatible Azide-Alkyne Click Reactions for Surface Decoration of Glyco-Engineered Cells
Marcus Gutmann et al.
CHEMBIOCHEM (2016)
Immediate-type hypersensitivity to polyethylene glycols: a review
E. Wenande et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2016)
PEGylation of Biopharmaceuticals: A Review of Chemistry and Nonclinical Safety Information of Approved Drugs
Peter L. Turecek et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Probing unnatural amino acid integration into enhanced green fluorescent protein by genetic code expansion with a high-throughput screening platform
Georg Wandrey et al.
JOURNAL OF BIOLOGICAL ENGINEERING (2016)
Enhancing Pharmacokinetics, Tumor Accumulation, and Antitumor Efficacy by Elastin-Like Polypeptide Fusion of Interferon Alpha
Jin Hu et al.
ADVANCED MATERIALS (2015)
Design Rationale and Development Approach for Pegfilgrastim as a Long-Acting Granulocyte Colony-Stimulating Factor
Tara Arvedson et al.
BIODRUGS (2015)
Protein-polymer conjugation - moving beyond PEGylation
Yizhi Qi et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2015)
Site-Specific PEGylation of Therapeutic Proteins
Jonathan K. Dozier et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Optimal PEGylation can Improve the Exposure of Interferon in the Lungs Following Pulmonary Administration
Victoria M. Mcleod et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Anti-PEG immunity: emergence, characteristics, and unaddressed questions
Qi Yang et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2015)
Bio-orthogonal Immobilization of Fibroblast Growth Factor 2 for Spatial Controlled Cell Proliferation
Tessa Luehmann et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2015)
Bio-orthogonal Immobilization of Fibroblast Growth Factor 2 for Spatial Controlled Cell Proliferation
Tessa Luehmann et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2015)
Transglutaminase-Based Chemo-Enzymatic Conjugation Approach Yields Homogeneous Antibody-Drug Conjugates
Patrick Dennler et al.
BIOCONJUGATE CHEMISTRY (2014)
How Type I Interferons Work in Multiple Sclerosis and Other Diseases: Some Unexpected Mechanisms
Anthony T. Reder et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2014)
Decoration of silk fibroin by click chemistry for biomedical application
Hongshi Zhao et al.
JOURNAL OF STRUCTURAL BIOLOGY (2014)
Pre-clinical toxicokinetics and safety study of M2ES, a PEGylated recombinant human endostatin, in rhesus monkeys
Lifang Guo et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2014)
High yield soluble bacterial expression and streamlined purification of recombinant human interferon α-2a
Regina L. Bis et al.
PROTEIN EXPRESSION AND PURIFICATION (2014)
PEGylation of interferon α2 improves lymphatic exposure after subcutaneous and intravenous administration and improves antitumour efficacy against lymphatic breast cancer metastases
Lisa M. Kaminskas et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Genetic Encoding of a Bicyclo[6.1.0]nonyne-Charged Amino Acid Enables Fast Cellular Protein Imaging by Metal-Free Ligation
Annika Borrmann et al.
CHEMBIOCHEM (2012)
Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation
Jacob Piehler et al.
IMMUNOLOGICAL REVIEWS (2012)
Characterization of the self-association of human interferon-a2b, albinterferon-a2b, and pegasys
Yiming Li et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Effect of PEGylation on Protein Hydrodynamics
Yatin R. Gokarn et al.
MOLECULAR PHARMACEUTICS (2012)
Arginine-Specific Modification of Proteins with Polyethylene Glycol
Marc A. Gauthier et al.
BIOMACROMOLECULES (2011)
Prolonged half-life and preserved enzymatic properties of factor IX selectively PEGylated on native N-glycans in the activation peptide
Henrik Ostergaard et al.
BLOOD (2011)
Structural Linkage between Ligand Discrimination and Receptor Activation by Type I Interferons
Christoph Thomas et al.
CELL (2011)
Density Contrast Sedimentation Velocity for the Determination of Protein Partial-Specific Volumes
Patrick H. Brown et al.
PLOS ONE (2011)
Sortase-catalyzed transformations that improve the properties of cytokines
Maximilian W. Popp et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Katrin Knop et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Benefits and Risks of Interferon Therapy for Hepatitis B
Robert Perrillo
HEPATOLOGY (2009)
Site-specific modification and PEGylation of pharmaceutical proteins mediated by transglutaminase
Angelo Fontana et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
The impact of PEGylation on biological therapies
Francesco M. Veronese et al.
BIODRUGS (2008)
Effect of PEGylation on the solution conformation of antibody fragments
Yanling Lu et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Interferons at age 50: past, current and future impact on biomedicine
Ernest C. Borden et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Sortagging: a versatile method for protein labeling
Maximilian W. Popp et al.
NATURE CHEMICAL BIOLOGY (2007)
GlycoPEGylation of recombinant therapeutic proteins produced in Escherichia coli
Shawn DeFrees et al.
GLYCOBIOLOGY (2006)
Adjuvant activity of interferon alpha: mechanism(s) of action
MG Tovey et al.
VACCINE (2006)
N-terminally PEGylated human interferon-beta-1a with improved pharmacokinetic properties and in vivo efficacy in a melanoma angiogenesis model
DP Baker et al.
BIOCONJUGATE CHEMISTRY (2006)
Structural and biophysical characterization of the 40 kDa PEG-interferon-α2a and its individual positional isomers
C Dhalluin et al.
BIOCONJUGATE CHEMISTRY (2005)
A long-acting, highly potent interferon alpha-2 conjugate created using site-specific PEGylation
MS Rosendahl et al.
BIOCONJUGATE CHEMISTRY (2005)
Expression, purification, and characterization of rat interferon-β, and preparation of an N-terminally PEGylated form with improved pharmacokinetic parameters
RM Arduini et al.
PROTEIN EXPRESSION AND PURIFICATION (2004)
Pegaspargase: a review of clinical studies
ML Graham
ADVANCED DRUG DELIVERY REVIEWS (2003)
Effect of pegylation on pharmaceuticals
JM Harris et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Use of peginterferon a1fa-2a (40 KD) (Pegasys®) for the treatment of hepatitis C
KR Reddy et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
Structural and biological characterization of pegylated recombinant interferon alpha-2b and its therapeutic implications
YS Wang et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
Size-distribution analysis of proteins by analytical ultracentrifugation: Strategies and application to model systems
P Schuck et al.
BIOPHYSICAL JOURNAL (2002)
Purification and conformational properties of a human interferon α2b produced in Escherichia coli
A Beldarraín et al.
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY (2001)
Rational design of a potent, long-lasting form of interferon:: A 40 kDa branched polyethylene glycol-conjugated interferon α-2a for the treatment of hepatitis C
P Bailon et al.
BIOCONJUGATE CHEMISTRY (2001)
Pegylated interferon-α2b:: Pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data
P Glue et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
Identification of the major positional isomer of pegylated interferon alpha-2b
YS Wang et al.
BIOCHEMISTRY (2000)
Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and Lamm equation modeling
P Schuck
BIOPHYSICAL JOURNAL (2000)
Share Paper
